This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Primary Care iSBIRT to Reduce Serious Teen Health Risks

This study has been withdrawn prior to enrollment.
(Grant application was not funded)
Sponsor:
Information provided by (Responsible Party):
John R Knight, MD, Boston Children's Hospital
ClinicalTrials.gov Identifier:
NCT00891631
First received: April 30, 2009
Last updated: October 6, 2016
Last verified: October 2016
April 30, 2009
October 6, 2016
September 2009
September 2011   (Final data collection date for primary outcome measure)
frequency of substance use and other risk behaviors [ Time Frame: 3 months ]
Same as current
Complete list of historical versions of study NCT00891631 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Primary Care iSBIRT to Reduce Serious Teen Health Risks
Primary Care Internet/Intranet-based Screening, Brief Intervention, and Referral to Treatment (iSBIRT) System to Reduce Serious Teen Health Risks
The goal of the project is to develop and test an internet/intranet-based Screening, Brief Intervention, and Referral to Treatment (iSBIRT) system for adolescents that targets a broad range of serious health-risks and problem behaviors.
We have previously developed and tested a computerized substance use screening and feedback program for adolescents. We will expand this program to include other serious health risks, enhance the feedback and health risk information adolescents will receive on the computer, develop Technological Extenders to extend the effect of the intervention, develop a training video and protocol for providers, and pilot test the system among adolescents coming for non-urgent care at a variety of primary care sites.
Interventional
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Screening
  • Substance-related Disorders
  • Depression
  • High-risk Sex
  • Behavioral: iSBIRT
    Participants will receive the internet/intranet based screening, brief intervention, and referral to treatment program.
    Other Name: SBIRT
  • Behavioral: iSBIRT/TE
    Participants will receive the internet/intranet screening, brief intervention, and referral to treatment system along with technological extenders
    Other Name: SBIRT
  • Experimental: iSBIRT
    Participants will complete the iSBIRT system.
    Intervention: Behavioral: iSBIRT
  • Experimental: iSBIRT/TE
    Participants will receive the internet/intranet screening, brief intervention, and referral to treatment system and technological extenders
    Intervention: Behavioral: iSBIRT/TE
  • No Intervention: TAU
    Participants will receive Treatment as Usual from their primary care provider.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
September 2011
September 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 12-21 years old
  • arriving for non-urgent care
  • provide informed assent/consent

Exclusion Criteria:

  • less than 6th grade reading level
  • unavailable for follow-up questionnaires
Sexes Eligible for Study: All
12 Years to 21 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00891631
iSBIRT RFA-od-09-003
Yes
Not Provided
Plan to Share IPD: No
John R Knight, MD, Boston Children's Hospital
Boston Children’s Hospital
Not Provided
Principal Investigator: John R Knight, MD Boston Children’s Hospital
Boston Children’s Hospital
October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP